| Trial ID: | L0306 |
| Source ID: | NCT00768638
|
| Associated Drug: |
Atorvastatin
|
| Title: |
Study of Atorvastatin Dose Dependent Reduction of Proteinuria
|
| Acronym: |
SARP
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease
|
| Interventions: |
DRUG: Atorvastatin|DRUG: Atorvastatin
|
| Outcome Measures: |
Primary: proteinuria, 6 months |
|
| Sponsor/Collaborators: |
Sponsor: Laval University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
23
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2008-10
|
| Completion Date: |
2014-06
|
| Results First Posted: |
|
| Last Update Posted: |
2015-04-29
|
| Locations: |
Hôtel-Dieu de Québec Hospital, Quebec, G1R2J6, Canada
|
| URL: |
https://clinicaltrials.gov/show/NCT00768638
|
